MAG
XENT

Millrace Asset Group’s Intersect ENT, Inc XENT Stock Holding History

Millrace Asset Group’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-100,000
Closed -$1.9M – 65
2016
Q1 		$1.9M Buy
100,000
+57,000
+133% +$1.03M 2.62% 14
2015
Q4 		$968K Buy
+43,000
New +$850K 1.01% 45

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millrace Asset Group's XENT Position: Q2 2016 in Review

Millrace Asset Group sold out of Intersect ENT, Inc (XENT) in Q2 2016, closing a stake of 100,000 shares — an estimated $1.9M sold.

Millrace Asset Group first reported a position in XENT in Q4 2015 and held it in 2 quarters. The position peaked at $1.9M in Q1 2016. 100 funds tracked by Wall St. Rank hold XENT as of Q2 2016.

  • Millrace Asset Group reported no remaining Intersect ENT, Inc position as of Q2 2016 after selling out during the quarter.
  • Millrace Asset Group sold 100,000 Intersect ENT, Inc shares in Q2 2016, an estimated $1.9M.
  • Millrace Asset Group first reported a position in Intersect ENT, Inc in Q4 2015 and held it in 2 quarters.
  • Millrace Asset Group's Intersect ENT, Inc position peaked at $1.9M in Q1 2016.
  • 100 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2016.

Based on Millrace Asset Group's 13F filing for Q2 2016, filed 15 Aug 2016.